Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Stomach”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04074343
What this trial is testing

TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroEsophageal Cancer
University of California, Irvine 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03641313
What this trial is testing

Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+5 more
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Study completedNCT01646476
What this trial is testing

Covered Versus Uncovered Self-expandable Metallic Stents for Malignant Gastric Outlet Obstruction

Who this might be right for
Gastric Outlet Obstruction Due to Gastric Adenocarcinoma
Samsung Medical Center 102
Testing effectiveness (Phase 2)Looking for participantsNCT07569068
What this trial is testing

Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ Adenocarcinoma

Who this might be right for
Gastric or Esophagogastric Junction Adenocarcinoma
Ruijin Hospital 88
Testing effectiveness (Phase 2)Study completedNCT00515411
What this trial is testing

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Cancer
Memorial Sloan Kettering Cancer Center 111
Not applicableApproved For MarketingNCT02307812
What this trial is testing

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Eli Lilly and Company
Early research (Phase 1)Looking for participantsNCT06675136
What this trial is testing

Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases

Who this might be right for
Clinical Stage IVB Gastric Cancer AJCC v8Metastatic Gastric AdenocarcinomaMetastatic Malignant Neoplasm in the Peritoneum
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT03259867
What this trial is testing

Combination of TATE and PD-1 Inhibitor in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaGastric Cancer
Teclison Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT01757171
What this trial is testing

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal AdenocarcinomaDistal Esophageal Adenocarcinoma
Weill Medical College of Cornell University 85
Testing effectiveness (Phase 2)Looking for participantsNCT06711471
What this trial is testing

Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer

Who this might be right for
Gastric Cancer Adenocarcinoma Metastatic
LIN YANG 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07709767
What this trial is testing

Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Tang-Du Hospital 21
Early research (Phase 1)Active Not RecruitingNCT05238922
What this trial is testing

Study of INCB123667 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 291
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)Looking for participantsNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more
Inhibrx Biosciences, Inc 340
Not applicableActive Not RecruitingNCT07429318
What this trial is testing

Efficacy and Survival Analysis of Perioperative Treatment of Locally Advanced Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 300
Testing effectiveness (Phase 2)Study completedNCT07529613
What this trial is testing

Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
National Cancer Center Hospital East 30
Testing effectiveness (Phase 2)Looking for participantsNCT06947291
What this trial is testing

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

Who this might be right for
Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 350
Testing effectiveness (Phase 2)Study completedNCT01514110
What this trial is testing

Gastric Cancer RAD001 Study

Who this might be right for
Gastric Cancer
Chinese University of Hong Kong 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05094336
What this trial is testing

Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

Who this might be right for
Advanced MTAP-null Solid Tumors
Amgen 329
Testing effectiveness (Phase 2)Active Not RecruitingNCT06628310
What this trial is testing

Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Who this might be right for
Locally Advanced Unresectable or Metastatic Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
AbbVie 185
Next Page